Forefront Medical Technology Announces Uniquely-Designed COVID-19 Test Swab
SINGAPORE – Forefront Medical Technology, a specialty medical contract manufacturer, has announced a uniquely-designed nasopharyngeal COVID-19 test swab. The EZYSWAB™ was originally developed to support the need for COVID-19 test swabs in Singapore and is now available for shipment worldwide.
“We worked with a team at the National University of Singapore to develop and manufacture a product that addressed a critical testing need in Singapore. We are now tooled at sufficient volume to support needs around the world,” said Walter Tarca, Forefront Medical Technology's president.
EZYSWAB's patented design offers patients and caregivers the best of both worlds: the flexibility of biocompatible nylon for ease of nasopharyngeal insertion and a Safe Break Point feature facilitating quick transfer to a sample collection tube.
The swab's flexibility combined with its Safe Break Point feature, also minimizes the risk of accidental breakage during the nasopharyngeal insertion procedure.
The swab tip's unique design has been clinically-proven to be effective in collecting samples for polymerase chain reaction (PCR) testing in both clinical trials and laboratories. When compared with a rigid swab, EZYSWAB's flexible design received higher patient comfort ratings.
Manufactured in Singapore, EZYSWAB™ is individually-packaged to maintain sterility and ease-of-use. Currently, average delivery time is 14 days and the product has a 3-year shelf life.
Additional information is available at www.forefrontmedical.com/EZYSWAB.
ABOUT FOREFRONT MEDICAL TECHNOLOGY
Founded in 2002 and headquartered in Singapore, Forefront Medical Technology (www.forefrontmedical.com) is a medical device contract manufacturer specializing in medical disposables, diagnostics, drug delivery products and electro-mechanical sub-components. Forefront Medical operates FDA registered and TUV ISO 13485 accredited, state-of-the-art manufacturing facilities in Singapore, Changzhou and Xiamen, PRC, and the U.K. Forefront is a wholly-owned subsidiary of VicPlas International (SGX:569).